A Vaccinia Virus Recombinant Transcribing an Alphavirus Replicon and Expressing Alphavirus Structural Proteins Leads to Packaging of Alphavirus Infectious Single Cycle Particles

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Sánchez Puig, Juana M ^a   Lorenzo, María M ^a   Blasco, Rafael ^a  

^a INIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVIRUS INFECTION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; REPLICON; SEMLIKI FOREST ALPHAVIRUS; VACCINIA VIRUS; VIRUS GENOME; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ALPHAVIRUS; DNA, COMPLEMENTARY; DNA, VIRAL; REPLICON; VACCINIA VIRUS; VIRAL STRUCTURAL PROTEINS;

EID: 84885148337     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075574     Document Type: Article

References (41)

1. Atkins GJ, Fleeton MN, Sheahan BJ, (2008) Therapeutic and prophylactic applications of alphavirus vectors. Expert Rev Mol Med 10: e33.
2. Quetglas JI, Ruiz-Guillen M, Aranda A, Casales E, Bezunartea J, et al. (2010) Alphavirus vectors for cancer therapy. Virus Res 153: 179-196.
3. Lundstrom K, (2002) Alphavirus-based vaccines. Curr Opin Mol Ther 4: 28-34.
4. Lundstrom K, (2003) Alphavirus vectors for vaccine production and gene therapy. Expert Rev Vaccines 2: 447-459.
5. Strauss JH, Strauss EG, (1994) The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 58: 491-562.
6. Liljestrom P, Garoff H, (1991) A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N Y) 9: 1356-1361.
7. Berglund P, Smerdou C, Fleeton MN, Tubulekas I, Liljestrom P, (1998) Enhancing immune responses using suicidal DNA vaccines. Nat Biotechnol 16: 562-565.
8. DiCiommo DP, Bremner R, (1998) Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem 273: 18060-18066.
9. Kohno A, Emi N, Kasai M, Tanimoto M, Saito H, (1998) Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death. Gene Ther 5: 415-418.
10. Pan Y, Zhao Q, Fang L, Luo R, Chen H, et al. (2009) Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon. J Gene Med 11: 1030-1038.
11. Liljeström P, Garoff H (1994) Expression of proteins using Semliki Forest Virus vectors. Current Potocols in Molecular Biology. New York: Wiley-Interscience.
12. Berglund P, Sjoberg M, Garoff H, Atkins GJ, Sheahan BJ, et al. (1993) Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology (N Y) 11: 916-920.
13. Smerdou C, Liljestrom P, (1999) Two-helper RNA system for production of recombinant Semliki forest virus particles. J Virol 73: 1092-1098.
14. Kamrud KI, Alterson K, Custer M, Dudek J, Goodman C, et al. (2010) Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle. J Gen Virol 91: 1723-1727.
15. Kamrud KI, Coffield VM, Owens G, Goodman C, Alterson K, et al. (2010) In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs. J Virol 84: 7713-7725.
16. Caplen NJ, Higginbotham JN, Scheel JR, Vahanian N, Yoshida Y, et al. (1999) Adeno-retroviral chimeric viruses as in vivo transducing agents. Gene Ther 6: 454-459.
17. Ramsey WJ, Caplen NJ, Li Q, Higginbotham JN, Shah M, et al. (1998) Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors. Biochem Biophys Res Commun 246: 912-919.
18. Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, et al. (2004) In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. J Gene Med 6: 288-299.
19. Feng M, Jackson WH Jr, Goldman CK, Rancourt C, Wang M, et al. (1997) Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat Biotechnol 15: 866-870.
20. Bilbao G, Feng M, Rancourt C, Jackson WH Jr, Curiel DT, (1997) Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo. FASEB J 11: 624-634.
21. Wahlfors JJ, Xanthopoulos KG, Morgan RA, (1997) Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells. Hum Gene Ther 8: 2031-2041.
22. Wahlfors JJ, Morgan RA, (1999) Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system. Hum Gene Ther 10: 1197-1206.
23. Li KJ, Garoff H, (1998) Packaging of intron-containing genes into retrovirus vectors by alphavirus vectors. Proc Natl Acad Sci U S A 95: 3650-3654.
24. Konetschny C, Holzer GW, Falkner FG, (2002) Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes. J Virol 76: 1236-1243.
25. Konetschny C, Holzer GW, Urban C, Hammerle T, Mayrhofer J, et al. (2003) Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus. J Virol 77: 7017-7025.
26. Falkner FG, Holzer GW, (2004) Vaccinia viral/retroviral chimeric vectors. Curr Gene Ther 4: 417-426.
27. Holzer GW, Falkner FG, (2003) Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles. Methods Mol Med 76: 565-578.
28. Holzer GW, Mayrhofer JA, Gritschenberger W, Dorner F, Falkner FG, (1999) Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles. Virology 253: 107-114.
29. Vasilakis N, Falvey D, Gangolli SS, Coleman J, Kowalski J, et al. (2003) Transfection-independent production of alphavirus replicon particles based on poxvirus expression vectors. Nat Biotechnol 21: 932-935.
30. Lorenzo MM, Galindo I, Blasco R, (2004) Construction and isolation of recombinant vaccinia virus using genetic markers. Methods Mol Biol 269: 15-30.
31. Sanchez-Puig JM, Lorenzo MM, Blasco R, (2012) Isolation of recombinant MVA using F13L selection. Methods Mol Biol 890: 93-111.
32. Barcena J, Lorenzo MM, Sanchez-Puig JM, Blasco R, (2000) Sequence and analysis of a swinepox virus homologue of the vaccinia virus major envelope protein P37 (F13L). J Gen Virol 81: 1073-1085.
33. Blasco R, Moss B, (1992) Role of cell-associated enveloped vaccinia virus in cell-to-cell virus spread. J Virol 66: 4170-4179.
34. Blasco R, Moss B, (1995) Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158: 157-162.
35. Usdin TB, Brownstein MJ, Moss B, Isaacs SN, (1993) SP6 RNA polymerase containing vaccinia virus for rapid expression of cloned genes in tissue culture. Biotechniques 14: 222-224.
36. Lorenzo MM, Galindo I, Griffiths G, Blasco R, (2000) Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon. J Virol 74: 10535-10550.
37. Lorenzo MM, Blasco R, (1998) PCR-based method for the introduction of mutations in genes cloned and expressed in vaccinia virus. Biotechniques 24: 308-313.
38. Dominguez J, Lorenzo MM, Blasco R, (1998) Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry. J Immunol Methods 220: 115-121.
39. Perdiguero B, Blasco R, (2006) Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins. J Virol 80: 8763-8777.
40. Glauert AM, (1974) The high voltage electron microscope in biology. J Cell Biol 63: 717-748.
41. Preibisch S, Saalfeld S, Tomancak P, (2009) Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics 25: 1463-1465.